Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Nohara Goto"'
Publikováno v:
Current Issues in Molecular Biology, Vol 45, Iss 4, Pp 3658-3673 (2023)
Cluster of differentiation 44 (CD44) is a type I transmembrane glycoprotein and has been shown to be a cell surface marker of cancer stem-like cells in various cancers. In particular, the splicing variants of CD44 (CD44v) are overexpressed in cancers
Externí odkaz:
https://doaj.org/article/b243de68e8f643f6849c3075db270083
Publikováno v:
Current Issues in Molecular Biology, Vol 45, Iss 3, Pp 1875-1888 (2023)
CD44 has been known as a marker of tumor-initiating cells, and plays pro-tumorigenic functions in many cancers. The splicing variants play critical roles in the malignant progression of cancers by promoting stemness, cancer cell invasion or metastasi
Externí odkaz:
https://doaj.org/article/4f6db199970243e79a0cf1256ff24d17
Autor:
Hiroyuki Suzuki, Nohara Goto, Tomohiro Tanaka, Tsunenori Ouchida, Mika K. Kaneko, Yukinari Kato
Publikováno v:
Antibodies, Vol 12, Iss 3, p 45 (2023)
Gastric cancer (GC) is the third leading cause of cancer-related deaths worldwide. GC with peritoneal metastasis exhibits a poor prognosis due to the lack of effective therapy. A comprehensive analysis of malignant ascites identified the genomic alte
Externí odkaz:
https://doaj.org/article/4f4857fb3d6b44b89173a572ef9a7035
Autor:
Nohara Goto, Hiroyuki Suzuki, Tomohiro Tanaka, Kenichiro Ishikawa, Tsunenori Ouchida, Mika K. Kaneko, Yukinari Kato
Publikováno v:
Antibodies, Vol 12, Iss 3, p 42 (2023)
Epidermal Growth Factor Receptor (EGFR) overexpression or its mutation mediates the sustaining proliferative signaling, which is an important hallmark of cancer. Human EGFR-targeting monoclonal antibody (mAb) therapy such as cetuximab has been approv
Externí odkaz:
https://doaj.org/article/fc3c797c5b0f4e47aee4bf092707c70e
Autor:
Hiroyuki Suzuki, Kaishi Kitamura, Nohara Goto, Kenichiro Ishikawa, Tsunenori Ouchida, Tomohiro Tanaka, Mika K. Kaneko, Yukinari Kato
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 9, p 8411 (2023)
Cluster of differentiation 44 (CD44) promotes tumor progression through the recruitment of growth factors and the acquisition of stemness, invasiveness, and drug resistance. CD44 has multiple isoforms including CD44 standard (CD44s) and CD44 variants
Externí odkaz:
https://doaj.org/article/7a5afe78ab0a42ba8ba724143f5a07ec
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 10, p 5535 (2022)
CD44 is a cell surface glycoprotein, which is expressed on normal cells, and overexpressed on cancer cells. CD44 is involved in cell adhesion, migration, proliferation, survival, stemness, and chemo−resistance. Therefore, CD44 is thought to be a pr
Externí odkaz:
https://doaj.org/article/a891a91d318142ab9af465744df94330
Autor:
Tomohiro Tanaka, Hiroyuki Suzuki, Yu Isoda, Teizo Asano, Takuro Nakamura, Miyuki Yanaka, Saori Handa, Nozomi Takahashi, Saori Okuno, Takeo Yoshikawa, Guanjie Li, Ren Nanamiya, Nohara Goto, Nami Tateyama, Yuki Okada, Hiyori Kobayashi, Mika K. Kaneko, Yukinari Kato
Publikováno v:
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41:303-310
Autor:
Ren Nanamiya, Hiroyuki Suzuki, Junko Takei, Guanjie Li, Nohara Goto, Hiroyuki Harada, Masaki Saito, Tomohiro Tanaka, Teizo Asano, Mika K. Kaneko, Yukinari Kato
Publikováno v:
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41:311-319
Autor:
Yu Isoda, Tomohiro Tanaka, Hiroyuki Suzuki, Teizo Asano, Takuro Nakamura, Miyuki Yanaka, Saori Handa, Yu Komatsu, Saori Okuno, Nozomi Takahashi, Yuki Okada, Hiyori Kobayashi, Guanjie Li, Ren Nanamiya, Nohara Goto, Nami Tateyama, Takeo Yoshikawa, Mika K. Kaneko, Yukinari Kato
Publikováno v:
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41:275-278
Autor:
Kato, Hiroyuki Suzuki, Nohara Goto, Tomohiro Tanaka, Tsunenori Ouchida, Mika K. Kaneko, Yukinari
Publikováno v:
Antibodies; Volume 12; Issue 3; Pages: 45
Gastric cancer (GC) is the third leading cause of cancer-related deaths worldwide. GC with peritoneal metastasis exhibits a poor prognosis due to the lack of effective therapy. A comprehensive analysis of malignant ascites identified the genomic alte